Optogenetic Activation of Brainstem Serotonergic Neurons Induces Persistent Pain Sensitization

Molecular Pain

Volumn 10, Issue , 2014, Pages

  Cai, You Qing ^a   Wang, Wei ^a   Hou, Yuan Yuan ^a   Pan, Zhizhong Z ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

5 HT; Descending facilitation; Optogenetic; Pain; Rostral ventromedial medulla; Serotonin

Indexed keywords

BACTERIAL PROTEIN; CHANNELRHODOPSIN 2, MOUSE; PHOTOPROTEIN; RHODOPSIN; TPH2 PROTEIN, MOUSE; TRYPTOPHAN HYDROXYLASE; YELLOW FLUORESCENT PROTEIN, BACTERIA;

ANALYSIS OF VARIANCE; ANIMAL; C57BL MOUSE; FEMALE; GENETICS; HYPERALGESIA; MALE; MEDULLA OBLONGATA; METABOLISM; MOUSE; OPTOGENETICS; PAIN THRESHOLD; PATHOLOGY; PHYSIOLOGY; SEROTONINERGIC NERVE CELL; TRANSGENIC MOUSE;

ANALYSIS OF VARIANCE; ANIMALS; BACTERIAL PROTEINS; FEMALE; HYPERALGESIA; LUMINESCENT PROTEINS; MALE; MEDULLA OBLONGATA; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; OPTOGENETICS; PAIN THRESHOLD; RHODOPSIN; SEROTONERGIC NEURONS; TRYPTOPHAN HYDROXYLASE;

EID: 84925284782     PISSN: None     EISSN: 17448069     Source Type: Journal    
DOI: 10.1186/1744-8069-10-70     Document Type: Article

References (46)

1. Basbaum Al Bautista DM Scherrer G Julius D: Cellular and molecular mechanisms of pain. Cell 2009, 139:267–284.
2. Fields H: State-dependent opioid control of pain. Nat Rev Neurosci 2004, 5:565–575.
3. Millan MJ: Descending control of pain. Prog Neurobiol 2002, 66:355–474.
4. Fields HL Heinricher MM Mason P: Neurotransmitters in nociceptive modulatory circuits. Annu Rev Neurosci 1991, 14:219–245.
5. Porreca F Ossipov MH Gebhart GF: Chronic pain and medullary descending facilitation. Trends Neurosci 2002, 25:319–325.
6. Gebhart GF: Descending modulation of pain. Neurosci Biobehav Rev 2004, 27:729–737.
7. Vanegas H Schaible HG: Descending control of persistent pain: Inhibitory or facilitatory? Brain Res Brain Res Rev 2004, 46:295–309.
8. Robinson DA Calejesan AA Wei F Gebhart GF Zhuo M: Endogenous facilitation: From molecular mechanisms to persistent pain. Curr Neurovasc Res 2004, 1:11–20.
9. Buhler AV Choi J Proudfit HK Gebhart GF: Neurotensin activation of the NTR1 on spinally-projecting serotonergic neurons in the rostral ventromedial medulla is antinociceptive. Pain 2005, 114:285–294.
10. Calejesan AA Ch'ang MH Zhuo M: Spinal serotonergic receptors mediate facilitation of a nociceptive reflex by subcutaneous formalin injection into the hindpaw in rats. Brain Res 1998, 798:46–54.
11. Hammond DL Yaksh TL: Antagonism of stimulation-produced antinociception by intrathecal administration of methysergide or phentolamine. Brain Res 1984, 298:329–337.
12. Wei F Dubner R Ren K: Nucleus reticularis gigantocellularis and nucleus raphe magnus in the brain stem exert opposite effects on behavioral hyperalgesia and spinal Fos protein expression after peripheral inflammation. Pain 1999, 80:127–141.
13. Zhao ZQ Chiechio S Sun YG Zhang KH Zhao CS Scott M Johnson RL Deneris ES Renner KJ Gereau RW Chen ZF: Mice lacking central serotonergic neurons show enhanced inflammatory pain and an impaired analgesic response to antidepressant drugs. J Neurosci 2007, 27:6045–6053.
14. Kim YS Chu Y Han L Li M Li Z Lavinka PC Sun S Tang Z Park K Caterina MJ Ren K Dubner R Wei F Dong X: Central Terminal Sensitization of TRPV1 by Descending Serotonergic Facilitation Modulates Chronic Pain. Neuron 2014, 81:873–887.
15. Wei F Dubner R Zou S Ren K Bai G Wei D Guo W: Molecular depletion of descending serotonin unmasks its novel facilitatory role in the development of persistent pain. J Neurosci 2010, 30:8624–8636.
16. Yizhar O Fenno LE Davidson TJ Mogri M Deisseroth K: Optogenetics in neural systems. Neuron 2011, 71:9–34.
17. Liu X Ramirez S Pang PT Puryear CB Govindarajan A Deisseroth K Tonegawa S: Optogenetic stimulation of a hippocampal engram activates fear memory recall. Nature 2012, 484:381–385.
18. Tye KM Prakash R Kim SY Fenno LE Grosenick L Zarabi H Thompson KR Gradinaru V Ramakrishnan C Deisseroth K: Amygdala circuitry mediating reversible and bidirectional control of anxiety. Nature 2011, 471:358–362.
19. Tye KM Deisseroth K: Optogenetic investigation of neural circuits underlying brain disease in animal models. Nat Rev Neurosci 2012, 13:251–266.
20. Ji G Neugebauer V: Modulation of medial prefrontal cortical activity using in vivo recordings and optogenetics. Mol Brain 2012, 5:36.
21. Daou I Tuttle AH Longo G Wieskopf JS Bonin RP Ase AR Wood JN De Koninck Y Ribeiro-da-Silva A Mogil JS Seguela P: Remote optogenetic activation and sensitization of pain pathways in freely moving mice. J Neurosci 2013, 33:18631–18640.
22. Crock LW Kolber BJ Morgan CD Sadler KE Vogt SK Bruchas MR Gereau RW: Central amygdala metabotropic glutamate receptor 5 in the modulation of visceral pain. J Neurosci 2012, 32:14217–14226.
23. Ito H Yanase M Yamashita A Kitabatake C Hamada A Suhara Y Narita M Ikegami D Sakai H Yamazaki M: Analysis of sleep disorders under pain using an optogenetic tool: Possible involvement of the activation of dorsal raphe nucleus-serotonergic neurons. Mol Brain 2013, 6:59.
24. Zhao S Ting JT Atallah HE Qiu L Tan J Gloss B Augustine GJ Deisseroth K Luo M Graybiel AM Feng G: Cell type-specific channelrhodopsin-2 transgenic mice for optogenetic dissection of neural circuitry function. Nat Methods 2011, 8:745–752.
25. Braz JM Basbaum AI: Genetically expressed transneuronal tracer reveals direct and indirect serotonergic descending control circuits. J Comp Neurol 2008, 507:1990–2003.
26. Braz JM Enquist LW Basbaum AI: Inputs to serotonergic neurons revealed by conditional viral transneuronal tracing. J Comp Neurol 2009, 514:145–160.
27. Rahman W Bauer CS Bannister K Vonsy JL Dolphin AC Dickenson AH: Descending serotonergic facilitation and the antinociceptive effects of pregabalin in a rat model of osteoarthritic pain. Mol Pain 2009, 5:45.
28. Okubo M Castro A Guo W Zou S Ren K Wei F Keller A Dubner R: Transition to persistent orofacial pain after nerve injury involves supraspinal serotonin mechanisms. J Neurosci 2013, 33:5152–5161.
29. Aimone LD Gebhart GF: Stimulation-produced spinal inhibition from the midbrain in the rat is mediated by an excitatory amino acid neurotransmitter in the medial medulla. J Neurosci 1986, 6:1803–1813.
30. Inase M Nakahama H Otsuki T Fang JZ: Analgesic effects of serotonin microinjection into nucleus raphe magnus and nucleus raphe dorsalis evaluated by the monosodium urate (MSU) tonic pain model in the rat. Brain Res 1987, 426:205–211.
31. Llewelyn MB Azami J Roberts MH: Effects of 5-hydroxytryptamine applied into nucleus raphe magnus on nociceptive thresholds and neuronal firing rate. Brain Res 1983, 258:59–68.
32. Marinelli S Vaughan CW Schnell SA Wessendorf MW Christie MJ: Rostral ventromedial medulla neurons that project to the spinal cord express multiple opioid receptor phenotypes. J Neurosci 2002, 22:10847–10855.
33. Wang H Wessendorf MW: Mu- and delta-opioid receptor mRNAs are expressed in spinally projecting serotonergic and nonserotonergic neurons of the rostral ventromedial medulla. J Comp Neurol 1999, 404:183–196.
34. Alhaider AA Lei SZ Wilcox GL: Spinal 5-HT3 receptor-mediated antinociception: Possible release of GABA. J Neurosci 1991, 11:1881–1888.
35. Green GM Scarth J Dickenson A: An excitatory role for 5-HT in spinal inflammatory nociceptive transmission; state-dependent actions via dorsal horn 5-HT(3) receptors in the anaesthetized rat. Pain 2000, 89:81–88.
36. Gu M Miyoshi K Dubner R Guo W Zou S Ren K Noguchi K Wei F: Spinal 5-HT(3) receptor activation induces behavioral hypersensitivity via a neuronal-glial-neuronal signaling cascade. J Neurosci 2011, 31:12823–12836.
37. Kayser V Elfassi IE Aubel B Melfort M Julius D Gingrich JA Hamon M Bourgoin S: Mechanical, thermal and formalin-induced nociception is differentially altered in 5-HT1A–/–, 5-HT1B–/–, 5-HT2A–/–, 5-HT3A–/–and 5-HTT–/– knock-out male mice. Pain 2007, 130:235–248.
38. Oatway MA Chen Y Weaver LC: The 5-HT3 receptor facilitates at-level mechanical allodynia following spinal cord injury. Pain 2004, 110:259–268.
39. Paul D Yao D Zhu P Minor LD Garcia MM: 5-hydroxytryptamine3 (5-HT3) receptors mediate spinal 5-HT antinociception: An antisense approach. J Pharmacol Exp Ther 2001, 298:674–678.
40. Svensson CI Tran TK Fitzsimmons B Yaksh TL Hua XY: Descending serotonergic facilitation of spinal ERK activation and pain behavior. FEBS Lett 2006, 580:6629–6634.
41. Zeitz KP Guy N Malmberg AB Dirajlal S Martin WJ Sun L Bonhaus DW Stucky CL Julius D Basbaum AI: The 5-HT3 subtype of serotonin receptor contributes to nociceptive processing via a novel subset of myelinated and unmyelinated nociceptors. J Neurosci 2002, 22:1010–1019.
42. Zhang L Hammond DL: Cellular basis for opioid potentiation in the rostral ventromedial medulla of rats with persistent inflammatory nociception. Pain 2010, 149:107–116.
43. Kuner R: Central mechanisms of pathological pain. Nat Med 2010, 16:1258–1266.
44. Chaplan SR Bach FW Pogrel JW Chung JM Yaksh TL: Quantitative assessment of tactile allodynia in the rat paw. J Neurosci Methods 1994, 53:55–63.
45. Cai YQ Chen SR Pan HL: Upregulation of nuclear factor of activated T-cells by nerve injury contributes to development of neuropathic pain. J Pharmacol Exp Ther 2013, 345:161–168.
46. Hargreaves K Dubner R Brown F Flores C Joris J: A new and sensitive method for measuring thermal nociception in cutaneous hyperalgesia. Pain 1988, 32:77–88.